The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
The industry rank for Srivichaivejvivat PCL's 9-Day RSI or its related term are showing as below:
BKK:VIH-R's 9-Day RSI is ranked worse than 83.05% of 702
companies
in the Healthcare Providers & Services industry
Industry Median: 46.32
vs BKK:VIH-R: 43.96
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
Srivichaivejvivat PCL 9-Day RSI Related Terms
BKK:VIH-R vs HCA, THC, DVA: 9-Day RSI Comparison
For the Medical Care Facilities subindustry, Srivichaivejvivat PCL's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Srivichaivejvivat PCL 9-Day RSI vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Srivichaivejvivat PCL's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where Srivichaivejvivat PCL's 9-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Srivichaivejvivat PCL (BKK:VIH-R) has a 9-Day RSI of 43.96 as of Jun. 26, 2026. According to the industry distribution chart, Srivichaivejvivat PCL ranks #583 out of 702 companies in the Healthcare Providers & Services industry, placing it in the top 83%.
Is Srivichaivejvivat PCL's 9-Day RSI too high?
Srivichaivejvivat PCL's current 9-Day RSI is 43.96. The Healthcare Providers & Services industry median 9-Day RSI is 46.32. Srivichaivejvivat PCL's value of 43.96 is 5.1% below this industry median. Based on the distribution chart, Srivichaivejvivat PCL ranks #583 out of 702 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Srivichaivejvivat PCL has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does Srivichaivejvivat PCL's 9-Day RSI compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Srivichaivejvivat PCL ranks #583 out of 702 companies for 9-Day RSI. This places Srivichaivejvivat PCL in the lower half of its industry. The industry median 9-Day RSI is 46.32. Srivichaivejvivat PCL's value of 43.96 is 5.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Healthcare Providers & Services company?
The median 9-Day RSI among Healthcare Providers & Services companies is 46.32, based on 702 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Srivichaivejvivat PCL's current 9-Day RSI of 43.96 is 5.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median 9-Day RSI is 46.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Srivichaivejvivat PCL's current 9-Day RSI is 43.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Srivichaivejvivat PCL stock overvalued right now?
Srivichaivejvivat PCL (BKK:VIH-R) has a current 9-Day RSI of 43.96. The stock's GF Value™ is ฿9.35, compared to a current price of ฿8.95 — trading 4.3% below its estimated fair value. The current 9-Day RSI is 43.96 and 5.1% below the Healthcare Providers & Services industry median of 46.32. Srivichaivejvivat PCL's overall GF Score™ is 80/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For Srivichaivejvivat PCL (BKK:VIH-R), the current 9-Day RSI is 43.96 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Srivichaivejvivat PCL (BKK:VIH-R) Overvalued in 2026?
Based on GuruFocus' analysis, Srivichaivejvivat PCL stock appears to be undervalued.
The current stock price of ฿8.95 is trading 4.3% below its estimated GF Value™ of ฿9.35.
Key valuation signals for BKK:VIH-R:
9-Day RSI: 43.96
GF Value™: ฿9.35 vs. price of ฿8.95 (4.3% below fair value)
Industry Position: 5.1% below the Healthcare Providers & Services median (#583 of 702)
No single metric tells the full story. See the BKK:VIH-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Srivichaivejvivat PCL is engaged in hospital business. The company provides 24-hour medical treatment by specialized doctors, with services in the outpatient department (OPD) by specialized doctors until midnight. Specialized clinics are available, such as comprehensive laparoscopic surgery, orthopedic surgery, urology, vascular surgery, cardiology, nephrology and hemodialysis center, endocrinology, neurology, gastroenterology, pediatric clinic, obstetrics and gynecology clinic, emergency accident center, dental center, health check-up center, Thai Filos Anti-Aging Center. It operates in single segment of hospital business in Thailand only.
80GF Score
Get the complete analysis for BKK:VIH-R
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:VIH-R has been successfully added to your 